Claude Nicaise insider trades

Open-market stock purchases and sales by Claude Nicaise, Director at Gain Therapeutics, Inc, from SEC Form 4 filings since Jun 2, 2015.

Recent trades

DateStockTradeValue
Jul 15, 2026GANX Gain Therapeutics, IncBought (not open market)—
Jun 4, 2026SRPT Sarepta Therapeutics, IncBought (not open market)—
Jan 29, 2026SRPT Sarepta Therapeutics, IncSold (not open market)$144K
Jan 29, 2026SRPT Sarepta Therapeutics, IncBought (not open market)—

Companies traded

  • GANX Gain Therapeutics, Inc: other filings, last Jul 15, 2026
  • SRPT Sarepta Therapeutics, Inc: 1 sale, last Jun 4, 2026
  • SAVA Cassava Sciences Inc: other filings, last May 23, 2025
  • CMMB Chemomab Therapeutics Ltd: other filings, last Mar 16, 2023

Get free alerts when Claude Nicaise files a new trade →